Content about Novartis Pharmaceuticals

May 10, 2013

FDA approves Novartis' Ilaris for rare childhood arthritis

The Food and Drug Administration has approved a biotech drug made by Novartis for treating a form of arthritis that affects children, the Swiss drug maker said Friday.

March 20, 2012

Novartis launches Arcapta Neohaler

Novartis has launched a new treatment for chronic obstructive pulmonary disease, the drug maker said Monday.

August 2, 2011

FDA gives new approval to Novartis MS drug

The Food and Drug Administration has approved a new use for a drug made by Novartis for treating multiple sclerosis, the Swiss drug maker's U.S. subsidiary said Monday.

January 3, 2011

Sandoz launches new dosages of authorized Lotrel generic

Sandoz has launched higher dosages of its authorized generic version of a hypertension drug, the generics division of Swiss drug maker Novartis said Monday.

December 23, 2010

FDA approves Novartis drug for high blood pressure treatment

The Food and Drug Administration on Wednesday approved Novartis Pharmaceuticals’ Amturnide (aliskiren, amlodipine and hydrochlorothiazide) tablets for the treatment of high blood pressure, according to the pharma company.

August 31, 2010

Community pharmacy leaders recognized by NACDS Foundation benefactors

The charitable arm of the National Association of Chain Drug Stores received contributions from several...

August 26, 2010

FDA approves single-pill combination of Novartis drugs for high blood pressure

The Food and Drug Administration has approved a single-pill combination of two drugs made by...